Type 2 diabetes affects hundreds of millions of people worldwide and is one of the leading causes of heart disease, kidney disease, vision problems, and other serious health conditions.
Although treatments can help control blood sugar levels, scientists have long been searching for ways to address the underlying causes of the disease. Now, new research from the University of Michigan has uncovered an important clue that could eventually lead to new treatments aimed at repairing damaged cells rather than simply managing symptoms.
The study, published in the journal Science, focuses on tiny structures inside our cells called mitochondria. These structures are often known as the “powerhouses” of the cell because they convert nutrients from food into the energy needed for the body to function. Every organ and tissue depends on healthy mitochondria to work properly.
Scientists have known for many years that mitochondria often become damaged in people with type 2 diabetes. In particular, damage has been found in specialized cells called beta cells, which are located in the pancreas. These cells are responsible for producing insulin, the hormone that helps move sugar from the bloodstream into the body’s cells for energy.
When beta cells cannot produce enough insulin, blood sugar levels begin to rise. Over time, high blood sugar can damage blood vessels, nerves, and organs throughout the body. However, researchers have not fully understood why damaged mitochondria cause beta cells to stop working properly.
To investigate this question, researchers used mice to study what happens when mitochondria inside beta cells become unhealthy. They focused on three important systems that help keep mitochondria functioning normally.
These included mitochondrial DNA, the process that removes damaged mitochondria, and quality-control systems that help maintain mitochondrial health.
The team discovered that when any of these systems failed, the same problem appeared. The damaged mitochondria sent stress signals throughout the cell. These signals caused the beta cells to lose some of their specialized features and begin behaving more like immature cells.
Immature cells cannot perform the important tasks of fully developed beta cells. As a result, they produce less insulin and are unable to help control blood sugar levels effectively. This finding helps explain why insulin production declines in type 2 diabetes.
The researchers also wondered whether the same process might occur in other parts of the body. Type 2 diabetes affects many organs, including the liver, muscles, and fat tissue. Problems in these tissues contribute to insulin resistance and other metabolic complications.
When the scientists examined liver cells and fat cells, they found a similar pattern. Damaged mitochondria caused these cells to become less mature and less able to perform their normal functions. This suggests that mitochondrial damage may be a common factor behind several of the body’s problems in type 2 diabetes.
According to the researchers, this discovery could help explain why diabetes affects so many different organs at the same time. Instead of being separate problems, many of the disease’s effects may stem from a shared process involving unhealthy mitochondria and stress signals inside cells.
One of the most exciting findings came when the researchers looked for ways to reverse the damage. Importantly, the affected cells were still alive. They had not died; they had simply lost some of their specialized abilities. This raised the possibility that the cells might be able to recover if the harmful stress signals could be blocked.
To test this idea, the team treated mice with a compound called ISRIB. This drug blocks a cellular stress response that becomes activated when mitochondria are damaged.
The results were remarkable. After four weeks of treatment, the beta cells began producing insulin again. The mice also showed normal blood sugar levels, suggesting that their cells had regained much of their normal function.
Senior researcher Dr. Scott A. Soleimanpour said the findings may reveal one of the major reasons why beta cells fail in type 2 diabetes. Even more importantly, the study suggests that this process may not be permanent. If scientists can find ways to repair or reverse the cellular changes, it could open the door to entirely new treatment approaches.
The researchers caution that the work is still at an early stage. The study was conducted in mice, and much more research will be needed before similar treatments can be tested in people. The team is now investigating the process in greater detail and plans to study human cells from individuals with diabetes.
If future research confirms the findings, the discovery could represent a major shift in diabetes treatment. Current therapies mainly focus on lowering blood sugar levels or helping the body use insulin more effectively.
A treatment that repairs damaged cells and restores insulin production would target a root cause of the disease rather than simply managing its symptoms.
Although it may take years before such treatments become available, the study offers new hope that type 2 diabetes could one day be treated in a way that restores healthy cell function and improves long-term outcomes for millions of people around the world.
Copyright © 2026 Knowridge Science Report. All rights reserved.
